ADS Processus Pharmatech, a pioneer in pharmaceutical technology, is excited to partner with Secoya to bring you the future of crystallization. The Secoya Crystallization Technology (SCT) is a game-changer, offering unparalleled control over the nucleation process. By precisely manipulating nucleation rates, SCT ensures consistent and efficient crystallization, leading to higher product yields and superior quality.

Secoya Crystallization Technology (SCT):

The SCT is a revolutionary technology that optimizes the nucleation process of molecules in solution. By precisely controlling nucleation rates within specific timeframes, SCT ensures that the process is both efficient and predictable. If you are looking to explore how such advanced technologies can be applied in different scientific fields, it might be helpful to consider having a bachelorarbeit schreiben lassen. This could provide a deeper understanding and detailed research into the mechanisms behind such innovations.

• Consistent Crystallization: Reliable and predictable outcomes across various molecules.
• Enhanced Efficiency: Increased product yields and reduced production time.
• Superior Quality: Improved purity and particle size distribution.

SCT Product Range:

• SCT-Lab 2.0: A compact and versatile solution for laboratory-scale research and development.
• SCT-PILOT: A scalable pilot-scale system for process optimization and validation.
• SCT-ICE Crystallization Unit: An industrial-scale solution for high-volume production.

By leveraging the power of SCT, ADS Processus Pharmatech and Secoya are empowering the pharmaceutical industry to achieve new heights in crystallization efficiency and product quality.